The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia
Open accessAbstract
The origin of inflammation in psychiatric disorders is not well understood. The translocation of commensal microbiota across the gastrointestinal barrier can result in a persistent state of low-grade immune activation and/or inflammation. We measured serological surrogate markers of bacterial translocation (soluble CD14 (sCD14) and lipopolysaccharide binding protein (LBP)) in two psychiatric cohorts and compared these levels to C-reactive protein (CRP), body mass index (BMI), and food-related and autoimmune antibodies. The two cohorts were composed of the following: (1) n=141 schizophrenia, n=75 bipolar disorder, n=78 controls; (2) n=78 antipsychotic-naïve first-episode schizophrenia, n=38 medicated first-episode schizophrenia. sCD14 seropositivity conferred a 3.1-fold increased odds of association with schizophrenia (multivariate regressions, OR=3.09, p<0.0001) compared to controls. Case-control differences in sCD14 were not matched by LBP. Quantitative levels of LBP, but not sCD14, correlated with BMI in schizophrenia (R(2)=0.21, p<0.0001). sCD14 and LBP also exhibited some congruency in schizophrenia with both significantly correlated with CRP (R(2)=0.26-0.27, p<0.0001) and elevated in females compared to males (p<0.01). Antipsychotic treatment generally did not impact sCD14 or LBP levels except for significant correlations, especially sCD14, with gluten antibodies in antipsychotic-naïve schizophrenia (R(2)=0.27, p<0.0001). In bipolar disorder, sCD14 levels were significantly correlated with anti-tissue transglutaminase IgG (R(2)=0.37, p<0.001). In conclusion, these bacterial translocation markers produced discordant and complex patterns of activity, a finding that may reflect an imbalanced, activated innate immune state. Whereas both markers may upregulate following systemic exposure to Gram-negative bacteria, non-lipopolysaccharide-based monocyte activation, autoimmunity and metabolic dysfunction may also contribute to the observed marker profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Researchers at Johns Hopkins University School of Medicine found evidence of increased gut bacterial translocation in schizophrenic patients, unrelated to antipsychotic treatment.”
From The Gut Microbiome and the Brain (2014) · cites this paper as [42]
In the citing paper
“suggesting that gut bacterial components other than LPS may be stimulating monocyte activation and inflammation in schizophrenics.42”
From The Gut Microbiome and the Brain (2014) · cites this paper as [42]
In the citing paper
“Presence of the translocation marker soluble CD14 tripled the risk of schizophrenia and was positively associated with C-reactive protein (CRP) but not with LPS-binding protein (LBP)”
From The Gut Microbiome and the Brain (2014) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 242
Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis
Misiak, B., Bartoli, F., Stramecki, F., Samochowiec, J., Lis, M., Kasznia, J., Jarosz, K., & Stańczykiewicz, B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.018 · Cited by 40
Gokulakrishnan, K., Nikhil, J., Sreeraj, V. S., Holla, B., Thirumoorthy, C., Narasimhan, S., Nichenametla, S., Pathak, H., Shivakumar, V., Debnath, M., et al. (2022) · Annals of Neurosciences · doi:10.1177/09727531221108849 · Cited by 41
Fond, G. B., Godin, O., Brunel, L., Aouizerate, B., Berna, F. S., Bulzacka, E., Capdevielle, D., Chéreau, I., Dorey, J., Dubertret, C., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.017 · Cited by 42
Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia
Debnath, M., & Berk, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0309-1 · Cited by 39
Fond, G. B., Resseguier, N., Schürhoff, F., Godin, O., Andrianarisoa, M., Brunel, L., Bulzacka, E., Aouizerate, B., Berna, F. S., Capdevielle, D., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0847-1 · Cited by 39
Cuomo, A., Maina, G., Rosso, G., Crescenzi, B. B., Bolognesi, S., Muro, A. D., Giordano, N. G., Goracci, A., Neal, S. M., Nitti, M. P., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01040 · Cited by 39
Deciphering microbiome and neuroactive immune gene interactions in schizophrenia
Severance, E. G., & Yolken, R. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.016 · Cited by 41
Self-citationWeber, N. S., Gressitt, K. L., Cowan, D. N., Niebuhr, D. W., Yolken, R. H., & Severance, E. G. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.12.016 · Cited by 37
Self-citationLi, W., Chen, M., Feng, X., Song, M., Shao, M., Yang, Y., Zhang, L., Liu, Q., Lv, L., & Su, X. (2021) · Brain and Behavior · doi:10.1002/brb3.2133 · Cited by 42
Kozłowska, E., Agier, J., Wysokiński, A., Łucka, A., Sobierajska, K., & Brzezińska‐Błaszczyk, E. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.138 · Cited by 37
Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia
Rowland, L. M., Demyanovich, H. K., Wijtenburg, S. A., Eaton, W. W., Rodriguez, K. M., Gaston, F. E., Čiháková, D., Talor, M. V., Liu, F., McMahon, R. R., et al. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00104 · Cited by 34
Karakuła‐Juchnowicz, H., Dzikowski, M., Pelczarska-Jamroga, A., Dzikowska, I., & Juchnowicz, D. (2015) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/45053 · Cited by 35
The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders
Faysal, M. F., Zehravi, M., Sutradhar, B., Amin, M. A., Shanmugarajan, T. S., Arjun, U. V. N. V., Ethiraj, S., Durairaj, A., Dayalan, G., Ahamad, S. K., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70593 · Cited by 41
IUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders
Lee, S.-H., Han, C., & Shin, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107749 · Cited by 38
Zádor, F., Nagy-Grócz, G., Kékesi, G., Dvorácskó, S., Szűcs, E., Tömböly, C., Horváth, G., Benyhe, S., & Vécsei, L. (2019) · Molecules · doi:10.3390/molecules24203709 · Cited by 33
Morris, G., Gamage, E., Travica, N., Berk, M., Jacka, F. N., O'Neil, A. E., Puri, B. K., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.036 · Cited by 31
Uranova, N. A., Бонарцев, П. Д., Андросова, Л. В., Рахманова, В. И., & Каледа, В. Г. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0782-1 · Cited by 30
Early Influences of Microbiota on White Matter Development in Germ-Free Piglets
Ahmed, S. A., Travis, S. D., Díaz-Bahamonde, F. V., Porter, D. D. L., Henry, S. N., Mykins, J., Ravipati, A., Booker, A., Ju, J., Ding, H., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.807170 · Cited by 31
From “Leaky Gut” to Impaired Glia-Neuron Communication in Depression
Rudzki, L., & Maes, M. H. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_9 · Cited by 31
Porcelli, B., Verdino, V., Bossini, L., Terzuoli, L., & Fagiolini, A. M. (2014) · Autoimmunity Highlights · doi:10.1007/s13317-014-0064-0 · Cited by 28
Complex Gastrointestinal and Endocrine Sources of Inflammation in Schizophrenia
Severance, E. G., Dickerson, F., & Yolken, R. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00549 · Cited by 29
Self-citationA review on the relationship between gluten and schizophrenia: Is gluten the cause?
Ergün, C., Urhan, M., & Ayer, A. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1313569 · Cited by 28
Infections, antibiotic treatment and the Microbiome in relation to schizophrenia
Klein‐Petersen, A. W., Köhler‐Forsberg, O., & Benros, M. E. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.033 · Cited by 28
Paton, S. E. J., Solano, J. L., Coulombe-Rozon, F., Lebel, M., & Ménard, C. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.220218 · Cited by 24
Dzikowski, M., Juchnowicz, D., Dzikowska, I., Róg, J., Próchnicki, M., Kozioł, M. M., & Karakuła‐Juchnowicz, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113707 · Cited by 24
The schizophrenia and gut microbiota: A bibliometric and visual analysis
Yang, C., Lin, X., Wang, X., Liu, H., Huang, J., & Wang, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1022472 · Cited by 26
Du, J., Huang, P., Qian, Y., Yang, X., Cui, S., Lin, Y., Gao, C., Zhang, P., He, Y., Xiao, Q., et al. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191612 · Cited by 24
Severance, E. G., Leister, F. J., Lea, A., Yang, S., Dickerson, F., & Yolken, R. H. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.02.001 · Cited by 24
Self-citationTonkaz, G. Y., ESİN, İ. S., Turan, B., Uslu, H., & Dursun, O. B. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05540-z · Cited by 23
Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set
Fond, G. B., Bulzacka, E., Boyer, L., Llorca, P., Godin, O., Brunel, L., Andrianarisoa, M., Aouizerate, B., Berna, F. S., Capdevielle, D., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0708-3 · Cited by 21
Scheurink, T. A. W., Borkent, J., Gangadin, S. S., Aidy, S. E., Mandl, R. C. W., & Sommer, I. E. (2023) · Brain and Behavior · doi:10.1002/brb3.3011 · Cited by 19
The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Severance, E. G., Tveiten, D., Lindström, L., Yolken, R. H., & Reichelt, K. L. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160914183804 · Cited by 21
Self-citationPentraxin 3 is reduced in bipolar disorder
Dickerson, F., Stallings, C. R., Origoni, A. E., Katsafanas, E., Schweinfurth, L. A. B., Savage, C. L. G., Khushalani, S., & Yolken, R. H. (2014) · Bipolar Disorders · doi:10.1111/bdi.12281 · Cited by 20
Self-citationGao, Y., Fan, Y., Yang, Z., Ma, Q., Zhao, B., He, X., Gao, F., Li, Q., Wang, W., Chen, C., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01362-0 · Cited by 20
Shi, J., Zhang, X., Chen, J., Shen, R.-S., Cui, H., & Wu, H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1275860 · Cited by 22
Borkent, J., Ioannou, M., Neijzen, D., Haarman, B. C. M., & Sommer, I. E. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae188 · Cited by 24
Delaney, S., & Hornig, M. (2018) · Current Environmental Health Reports · doi:10.1007/s40572-018-0186-z · Cited by 21
Campanale, A., Inserra, A., & Comai, S. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111058 · Cited by 19
Johansson, V., Jakobsson, J., Fortgang, R. G., Zetterberg, H., Blennow, K., Cannon, T. D., Hultman, C. M., Wetterberg, L., & Landén, M. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0759-5 · Cited by 18
Miranda-Ribera, A., Serena, G., Liu, J., Fasano, A., Kingsbury, M. A., & Fiorentino, M. R. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.2000299 · Cited by 18
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Prospects and Pitfalls of Plasma Complement C4 in Schizophrenia: Building a Better Biomarker
Severance, E. G., Prandovszky, E., Yang, S., Leister, F. J., Lea, A., Wu, C., Tamouza, R., Leboyer, M., Dickerson, F., & Yolken, R. H. (2023) · Developmental Neuroscience · doi:10.1159/000534185 · Cited by 16
Self-citationSchizophrenia Hypothesis: Autonomic Nervous System Dysregulation of Fetal and Adult Immune Tolerance
Carnac, T. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.844383 · Cited by 18
Romero‐Miguel, D., Casquero‐Veiga, M., Fernández, J., Lamanna‐Rama, N., Gómez‐Rangel, V., Gálvez-Robleño, C., Santa-Marta, C., Villar, C. J., Lombó, F., Abalo, R., et al. (2023) · Antioxidants · doi:10.3390/antiox12040970 · Cited by 18
Barbosa, I. G., de Miranda, A. S., Berk, M., & Teixeira, A. L. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2438646 · Cited by 16
Caffeine consumption and schizophrenia: A highlight on adenosine receptor–independent mechanisms
Huang, L., & Sperlágh, B. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.003 · Cited by 17
Ioannou, M., Borkent, J., Severance, E. G., Yolken, R. H., Fasano, A., Sommer, I. E., & Haarman, B. C. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111405 · Cited by 14
Self-citationThe role of infections and inflammation in schizophrenia: review of the evidence
Ahmed, G. K., Ramadan, H. K., Elbeh, K., & Haridy, N. A. (2024) · Middle East Current Psychiatry · doi:10.1186/s43045-024-00397-7 · Cited by 16
The effect of clozapine on immune-related biomarkers in schizophrenia patients
Shao, L., Yu, L., Yuan, Z., Guo, X., Zeng, G., & Liu, J. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111104 · Cited by 13
González-Blanco, L., Santo, F. D., García‐Portilla, M. P., Alfonso, M., Hernández, C., Sánchez-Autet, M., Anmella, G., Amoretti, S., Safont, G., Martín‐Hernández, D., et al. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1765 · Cited by 15
Chrobak, A. A., Nowakowski, J., & Dudek, D. (2016) · Archives of Psychiatry and Psychotherapy · doi:10.12740/app/62962 · Cited by 15
Gut Microorganisms and Neurological Disease Perspectives
Faruqui, N. A., Prium, D. H., Mowna, S. A., Ullah, M. A., Araf, Y., Sarkar, B., Zohora, U. S., & Rahman, M. S. (2021) · Future Neurology · doi:10.2217/fnl-2020-0026 · Cited by 15
Martín‐Hernández, D., Muñoz‐López, M., Tendilla‐Beltrán, H., Caso, J. R., García‐Bueno, B., Menchen, L. A., & Leza, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612634 · Cited by 12
Association of gut dysbiosis with first‑episode psychosis (Review)
Theleritis, C. G., Stefanou, M., Demetriou, M., Alevyzakis, E., Τriantafyllou, Κ., Smyrnis, N., Spandidos, D. A., & Rizos, E. N. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13254 · Cited by 13
Bui, T. A., O’Croinin, B. R., Dennett, L., Winship, I. R., & Greenshaw, A. J. (2025) · Microbiology · doi:10.1099/mic.0.001568 · Cited by 14
Just, D., Rasmusson, A. J., Nilsson, P., Noreland, M., Malmström, E., Brodin, P., Månberg, A., & Cunningham, J. L. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105162 · Cited by 12
Tracking a dysregulated gut-brain axis with biomarkers of the microbiome
Severance, E. G., & Yolken, R. H. (2019) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2019.100009 · Cited by 12
Self-citationSanto, F. D., González-Blanco, L., García‐Portilla, M. P., Alfonso, M., Hernández, C., Sánchez-Autet, M., Bernardo, M., Anmella, G., Amoretti, S., Safont, G., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.10.004 · Cited by 11
Weickert, T. W., Ji, E., Galletly, C. A., Boerrigter, D., Morishima, Y., Bruggemann, J. M., Balzan, R. P., O׳Donnell, M., Liu, D., Lenroot, R., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad171 · Cited by 12
Fond, G. B., Chevalier, G., Eberl, G., & Leboyer, M. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.10.016 · Cited by 14
Six Decades of Dopamine Hypothesis: Is Aryl Hydrocarbon Receptor the New D2?
Sfera, A. (2023) · Reports — Medical Cases Images and Videos · doi:10.3390/reports6030036 · Cited by 10
Melbourne, J. K., Rosen, C., Feiner, B., Pang, Y., & Sharma, R. P. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.317 · Cited by 10
Role of Immune and Autoimmune Dysfunction in Schizophrenia
Severance, E. G., & Yolken, R. H. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00029-8 · Cited by 8
Self-citationA study on the association of mood disorders and gluten-related diseases
Porcelli, B., Verdino, V., Ferretti, F., Bizzaro, N., Terzuoli, L., Cinci, F., Bossini, L., & Fagiolini, A. M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.008 · Cited by 9
Microbiome: The Missing Link in Neuropsychiatric Disorders
Evrensel, A., & Ceylan, M. E. (2017) · EMJ Innovation · doi:10.33590/emjinnov/10313424 · Cited by 9
Açıkel, S. B., Kara, A., Bağcı, Z., & Can, Ü. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10287 · Cited by 8
The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective
Su, B.-W., Li, Y., Yang, L.-Y., Yang, H., Wang, W., Ren, H., Bao, Y.-N., Lao, J.-Y., & Luan, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711756 · Cited by 11
Microbiota–Gut–Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders
Shin, C., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_2 · Cited by 10
MacDowell, K. S., Martín‐Hernández, D., Ulecia-Morón, C., Bris, Á. G., Madrigal, J. L. M., García‐Bueno, B., & Caso, J. R. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107217 · Cited by 8
Microbiota-Immune System Interactions in Human Neurological Disorders
Huang, Q., Fang, Y., Liao, D., & Xia, J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200726222138 · Cited by 7
Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review
Li, J., Zhao, W., & Wang, Y. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01558-1 · Cited by 7
Microbiome and Schizophrenia: Current Evidence and Future Challenges
Cordeiro, T. M. E., Zhang, X., Graubics, K., Colwell, R. R., & Teixeira, A. L. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00206-5 · Cited by 7
Kalaga, P., & Ray, S. K. (2025) · Brain Sciences · doi:10.3390/brainsci15020197 · Cited by 6
Binić, I., Petrovic, J., Žikić, O., Tošić-Golubović, S., Djordjevic, V., Stevanovic, M., Krtinić, D., & Apostolovic, M. A. (2025) · Brain Sciences · doi:10.3390/brainsci15090932 · Cited by 6
Crockett, A. M., Kébir, H., Anderson, S. A., Jyonouchi, S. C., Romberg, N. D., & Alvarez, J. I. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01686-w · Cited by 6
Сопряженность процессов системного воспаления и системной эндотоксинемии при эндогенных психозах
Zozulya, S. A., Otman, I. N., Oleichik, I. V., Anikhovskaya, I. A., Яковлев, М. Ю., & Klyushnik, T. P. (2020) · Сибирский вестник психиатрии и наркологии · doi:10.26617/1810-3111-2020-3(108)-17-27 · Cited by 6
Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia
Tsytsarev, V., Vaganova, A. N., Volnova, A. B., Fesenko, Z. S., Getachew, B., Gainetdinov, R. R., & Tizabi, Y. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04525-5 · Cited by 5
Kozłowska, E., Żelechowska, P., Wysokiński, A., Rasmus, P., Łucka, A., & Brzezińska‐Błaszczyk, E. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000964 · Cited by 5
The Role of Lactylation in Mental Illness: Emphasis on Microglia
Sfera, A., Klein, C. A., Anton, J. J., Kozlakidis, Z., & Andronescu, C. V. (2023) · Neuroglia · doi:10.3390/neuroglia4020009 · Cited by 5
Thisayakorn, P., Thipakorn, Y., Tantavisut, S., Sirivichayakul, S., Vojdani, A., & Maes, M. H. J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1294689 · Cited by 6
Szablewski, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00065-6 · Cited by 5
Şizofreni Etyolojisinde Mikrobiyotanın Rolü
Kartalcı, Ş. (2017) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.358105 · Cited by 7
Kanda, A., Mazumder, A., Das, S., & Prabhakar, V. (2023) · Journal of Natural Remedies · doi:10.18311/jnr/2023/33944 · Cited by 4
Gut-Brain Axis: The Role of Gut Microbiota in the Psychiatric Disorders
Evrensel, A., & Ceylan, M. E. (2015) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20150128123852 · Cited by 4
Tomaka, J., Karakuła‐Juchnowicz, H., Morylowska-Topolska, J., Dzikowski, M., Juchnowicz, D., Flis, M., Siek, A., & Próchnicki, M. (2017) · Current Problems of Psychiatry · doi:10.1515/cpp-2017-0001 · Cited by 4
From "Leaky Gut" to Impaired Glia-neuron Communication in DepressionPreprint
Rudzki, L., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202006.0058.v1 · Cited by 4
Petruso, F., Giff, A. E., Milano, B. A., Rossi, M. M. D., & Saccaro, L. F. (2023) · doi:10.31234/osf.io/2rnk8 · Cited by 4
Halverson, T., & Alagiakrishnan, K. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin36616 · Cited by 4
Mukherjee, K., Guest, P. C., Nussbaumer, M., Dudeck, L., Asl, L. S., Meyer-Lotz, G., Dobrowolny, H., Borucki, K., Bernstein, H., Link, A., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03584-3 · Cited by 2
The Influence of Gut Microbiota in Psychosis
Murray, N., Ghomi, R. H., Nemani, K., & O’Connor, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00018-7 · Cited by 3
Neurodevelopmental implications of COVID-19-induced gut microbiome dysbiosis in pregnant women
Wilson, J. D., Dworsky‐Fried, M., & Ismail, N. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104300 · Cited by 5
Jansma, J., van Essen, R., Haarman, B. C. M., Chatziioannou, A. C., Borkent, J., Ioannou, M., van Hemert, S., Sommer, I. E., & Aidy, S. E. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.05.011 · Cited by 3
Wpływ mikrobioty jelitowej na występowanie zaburzeń psychicznych oraz chorób neurodegeneracyjnych
Frej−Mądrzak, M., Kołodziej, P., Sarowska, J., & Jama−Kmiecik, A. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0021 · Cited by 3
Chandran, S., Manohari, S. M., & Raman, V. (2019) · Telangana Journal of Psychiatry · doi:10.18231/j.tjp.2019.022 · Cited by 4
Birth by cesarean section and schizophrenia. Results from the multi-center FACE-SZ dataset
Fond, G. B., Boyer, L., Llorca, P., & Leboyer, M. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.073 · Cited by 3
Fond, G. B., Godin, O., Llorca, P., & Leboyer, M. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.072 · Cited by 3
Insulin resistance in patients with schizophrenia: is it related to gut permeability?
Couce-Sánchez, M., Santo, F. D., González-Blanco, L., Paniagua, G., Rodríguez-Revuelta, J., Sáiz, P. A., & García‐Portilla, M. P. (2025) · Schizophrenia · doi:10.1038/s41537-025-00688-w · Cited by 2
The role of environmental factors in the etiology of schizophrenia
Brzuszkiewicz, K., Rudziński, G., Łozowski, B., Raczkiewicz, P., Kusak, N., & Soroka, E. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.23.01.006 · Cited by 3
The Role of Inflammatory Processes in the Etiopathogenesis of Schizophrenia
Rudkowski, K., Samochowiec, J., Kucharska–Mazur, J., & Mazur, A. (2023) · Archives of Psychiatry and Psychotherapy · doi:10.12740/app/163306 · Cited by 2
Rachana, R., Devtalla, H., Rana, K., Panda, S. P., Agrawal, A., Kadyan, S., Jindal, D., Pancham, P., Yadav, D., Jha, N. K., et al. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14374 · Cited by 4
Metadata
- Authors
- Severance, E. G., Gressitt, K. L., Stallings, C. R., Origoni, A. E., Khushalani, S., Leweke, F. M., Dickerson, F. B., & Yolken, R. H.
- Affiliations
- Johns Hopkins University (US)
- Sheppard and Enoch Pratt Hospital (US)
- University of Cologne (DE)
- Corresponding author
- Severance, Emily G.
- ORCID
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 148
- Issue
- 1-3
- Pages
- 130-137
- ISSN
- 0920-9964 (ISSN-L)
- PMC
- PMC3732507
- OpenAlex
- W2106172174
- Cited by
- 243
- References
- 74
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 18 · 2023: 22 · 2022: 13 · 2021: 23 · 2020: 23 · 2019: 23 · 2018: 22 · 2017: 17 · 2016: 24 · 2015: 19 · 2014: 13 · 2013: 3
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH‑94268, P50MH094268)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08HD073315)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- bacterial translocation, soluble CD14
- MeSH terms
- Lipopolysaccharide-Binding Protein, Acute-Phase Proteins, Adult, Analysis of Variance, Autoantibodies, Bipolar Disorder, C-Reactive Protein, Carrier Proteins, Female, Humans, Male, Membrane Glycoproteins, Regression Analysis, Schizophrenia, Cohort Studies, Body Mass Index, Lipopolysaccharide Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review